APA

Bruzzone M., Centurioni M. G., Giglione P., Gualco M., Merlo D. F., Miglietta L., Cosso M., Giannelli F., Cristoforoni P. & Ferrarini M. (20110928). Second-line treatment with intravenous gemcitabine and oral etoposide in platinum-resistant advanced ovarian cancer patients: results of a phase II study. : Oncology.

Chicago

Bruzzone M, Centurioni M G, Giglione P, Gualco M, Merlo D F, Miglietta L, Cosso M, Giannelli F, Cristoforoni P and Ferrarini M. 20110928. Second-line treatment with intravenous gemcitabine and oral etoposide in platinum-resistant advanced ovarian cancer patients: results of a phase II study. : Oncology.

Harvard

Bruzzone M., Centurioni M. G., Giglione P., Gualco M., Merlo D. F., Miglietta L., Cosso M., Giannelli F., Cristoforoni P. and Ferrarini M. (20110928). Second-line treatment with intravenous gemcitabine and oral etoposide in platinum-resistant advanced ovarian cancer patients: results of a phase II study. : Oncology.

MLA

Bruzzone M, Centurioni M G, Giglione P, Gualco M, Merlo D F, Miglietta L, Cosso M, Giannelli F, Cristoforoni P and Ferrarini M. Second-line treatment with intravenous gemcitabine and oral etoposide in platinum-resistant advanced ovarian cancer patients: results of a phase II study. : Oncology. 20110928.